Market Closed -
Deutsche Boerse AG
20:50:23 14/06/2024 BST
|
5-day change
|
1st Jan Change
|
24.35
EUR
|
-0.45%
|
|
-1.14%
|
-5.40%
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
7,029,161
|
5,153,364
|
6,229,971
|
5,423,454
|
6,762,204
|
6,498,524
|
-
|
-
|
Enterprise Value (EV)
1 |
12,054,743
|
9,609,054
|
9,862,522
|
8,919,170
|
10,611,015
|
10,950,330
|
10,687,037
|
10,335,859
|
P/E ratio
|
40
x
|
118
x
|
16.6
x
|
23.8
x
|
21.3
x
|
45.4
x
|
64.1
x
|
28.4
x
|
Yield
|
3.98%
|
5.44%
|
4.52%
|
5.15%
|
4.14%
|
4.49%
|
4.69%
|
4.81%
|
Capitalization / Revenue
|
3.35
x
|
1.57
x
|
1.95
x
|
1.52
x
|
1.68
x
|
1.54
x
|
1.52
x
|
1.5
x
|
EV / Revenue
|
5.75
x
|
2.92
x
|
3.08
x
|
2.5
x
|
2.63
x
|
2.57
x
|
2.5
x
|
2.38
x
|
EV / EBITDA
|
25.3
x
|
14
x
|
9.23
x
|
8.54
x
|
9.19
x
|
11.6
x
|
9.7
x
|
8.65
x
|
EV / FCF
|
-4.81
x
|
9.99
x
|
16
x
|
8.92
x
|
28.7
x
|
43.4
x
|
15.7
x
|
15.7
x
|
FCF Yield
|
-20.8%
|
10%
|
6.26%
|
11.2%
|
3.49%
|
2.31%
|
6.39%
|
6.38%
|
Price to Book
|
1.36
x
|
1.09
x
|
1.2
x
|
0.95
x
|
1.06
x
|
0.9
x
|
0.92
x
|
0.95
x
|
Nbr of stocks (in thousands)
|
1,554,780
|
1,557,849
|
1,563,355
|
1,550,444
|
1,554,530
|
1,568,934
|
-
|
-
|
Reference price
2 |
4,521
|
3,308
|
3,985
|
3,498
|
4,350
|
4,142
|
4,142
|
4,142
|
Announcement Date
|
14/05/19
|
13/05/20
|
11/05/21
|
11/05/22
|
11/05/23
|
09/05/24
|
-
|
-
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
2,097,200
|
3,291,200
|
3,197,812
|
3,569,006
|
4,027,478
|
4,263,762
|
4,268,729
|
4,339,235
|
EBITDA
1 |
477,415
|
684,057
|
1,068,940
|
1,043,995
|
1,154,905
|
942,077
|
1,101,766
|
1,194,359
|
EBIT
1 |
205,000
|
100,400
|
509,269
|
460,844
|
490,505
|
214,100
|
292,184
|
434,785
|
Operating Margin
|
9.77%
|
3.05%
|
15.93%
|
12.91%
|
12.18%
|
5.02%
|
6.84%
|
10.02%
|
Earnings before Tax (EBT)
1 |
94,896
|
-60,754
|
366,235
|
302,571
|
375,090
|
52,791
|
112,443
|
304,432
|
Net income
1 |
109,100
|
44,200
|
376,005
|
230,059
|
317,017
|
144,067
|
103,058
|
230,895
|
Net margin
|
5.2%
|
1.34%
|
11.76%
|
6.45%
|
7.87%
|
3.38%
|
2.41%
|
5.32%
|
EPS
2 |
113.0
|
28.00
|
240.7
|
147.1
|
204.3
|
92.09
|
64.64
|
145.7
|
Free Cash Flow
1 |
-2,507,219
|
961,871
|
617,401
|
999,853
|
370,054
|
252,482
|
682,369
|
659,391
|
FCF margin
|
-119.55%
|
29.23%
|
19.31%
|
28.01%
|
9.19%
|
5.92%
|
15.99%
|
15.2%
|
FCF Conversion (EBITDA)
|
-
|
140.61%
|
57.76%
|
95.77%
|
32.04%
|
26.8%
|
61.93%
|
55.21%
|
FCF Conversion (Net income)
|
-
|
2,176.18%
|
164.2%
|
434.61%
|
116.73%
|
175.25%
|
662.12%
|
285.58%
|
Dividend per Share
2 |
180.0
|
180.0
|
180.0
|
180.0
|
180.0
|
188.0
|
194.3
|
199.3
|
Announcement Date
|
14/05/19
|
13/05/20
|
11/05/21
|
11/05/22
|
11/05/23
|
09/05/24
|
-
|
-
|
Fiscal Period: March |
2020 S1
|
2020 S2
|
2021 S1
|
2022 Q2
|
2022 S1
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 S1
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 S1
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
2025 S1
|
2025 Q3
|
2025 Q4
|
2026 S1
|
---|
Net sales
1 |
1,660,200
|
1,631,000
|
1,590,785
|
844,797
|
1,794,400
|
901,294
|
873,289
|
972,465
|
1,002,340
|
1,974,800
|
1,096,551
|
956,200
|
1,058,618
|
1,043,089
|
2,101,707
|
1,111,200
|
1,050,869
|
1,073,112
|
1,080,400
|
2,126,400
|
1,139,257
|
1,062,529
|
2,137,000
|
EBITDA
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
249,972
|
340,072
|
133,355
|
-
|
291,975
|
176,675
|
320,925
|
282,725
|
-
|
368,925
|
202,525
|
-
|
EBIT
1 |
50,300
|
50,100
|
215,588
|
97,448
|
346,000
|
116,484
|
-1,619
|
150,515
|
104,485
|
255,000
|
146,990
|
88,600
|
168,571
|
-49,341
|
119,230
|
104,900
|
-10,055
|
87,880
|
73,125
|
137,550
|
74,350
|
29,175
|
239,500
|
Operating Margin
|
3.03%
|
3.07%
|
13.55%
|
11.54%
|
19.28%
|
12.92%
|
-0.19%
|
15.48%
|
10.42%
|
12.91%
|
13.4%
|
9.27%
|
15.92%
|
-4.73%
|
5.67%
|
9.44%
|
-0.96%
|
8.19%
|
6.77%
|
6.47%
|
6.53%
|
2.75%
|
11.21%
|
Earnings before Tax (EBT)
1 |
-27,557
|
-33,197
|
125,561
|
61,447
|
284,425
|
72,193
|
-54,047
|
155,473
|
64,549
|
220,022
|
107,153
|
47,900
|
135,033
|
-95,980
|
39,053
|
61,300
|
-47,500
|
60,840
|
44,187
|
57,650
|
35,554
|
-8,513
|
156,500
|
Net income
1 |
33,200
|
11,000
|
86,548
|
-16,778
|
183,600
|
57,769
|
-11,358
|
105,014
|
61,786
|
166,800
|
119,127
|
31,100
|
89,395
|
-48,030
|
41,365
|
105,700
|
-3,000
|
54,116
|
40,154
|
59,800
|
33,654
|
-2,013
|
120,500
|
Net margin
|
2%
|
0.67%
|
5.44%
|
-1.99%
|
10.23%
|
6.41%
|
-1.3%
|
10.8%
|
6.16%
|
8.45%
|
10.86%
|
3.25%
|
8.44%
|
-4.6%
|
1.97%
|
9.51%
|
-0.29%
|
5.04%
|
3.72%
|
2.81%
|
2.95%
|
-0.19%
|
5.64%
|
EPS
2 |
21.00
|
-
|
55.45
|
-10.27
|
117.0
|
37.01
|
-6.950
|
67.94
|
40.06
|
108.0
|
76.70
|
20.03
|
57.51
|
-31.00
|
26.51
|
67.38
|
-1.920
|
32.13
|
23.80
|
47.50
|
24.35
|
-6.569
|
76.80
|
Dividend per Share
2 |
90.00
|
-
|
90.00
|
-
|
90.00
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
94.00
|
94.00
|
-
|
94.00
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
31/10/19
|
13/05/20
|
29/10/20
|
28/10/21
|
28/10/21
|
03/02/22
|
11/05/22
|
28/07/22
|
27/10/22
|
27/10/22
|
02/02/23
|
11/05/23
|
27/07/23
|
26/10/23
|
26/10/23
|
01/02/24
|
09/05/24
|
-
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
5,025,582
|
4,455,690
|
3,632,551
|
3,495,716
|
3,848,811
|
4,385,952
|
4,188,513
|
3,837,335
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
10.53
x
|
6.514
x
|
3.398
x
|
3.348
x
|
3.333
x
|
4.656
x
|
3.802
x
|
3.213
x
|
Free Cash Flow
1 |
-2,507,219
|
961,871
|
617,401
|
999,853
|
370,054
|
252,482
|
682,369
|
659,391
|
ROE (net income / shareholders' equity)
|
3%
|
0.9%
|
7.6%
|
4.2%
|
5.3%
|
2.1%
|
1.42%
|
3.17%
|
ROA (Net income/ Total Assets)
|
1.06%
|
-0.46%
|
2.85%
|
2.32%
|
2.76%
|
0.36%
|
0.82%
|
1.93%
|
Assets
1 |
10,334,963
|
-9,710,018
|
13,209,937
|
9,918,859
|
11,467,260
|
39,661,656
|
12,574,212
|
11,944,912
|
Book Value Per Share
2 |
3,319
|
3,032
|
3,309
|
3,666
|
4,087
|
4,636
|
4,503
|
4,347
|
Cash Flow per Share
2 |
397.0
|
403.0
|
599.0
|
520.0
|
632.0
|
557.0
|
683.0
|
669.0
|
Capex
1 |
134,114
|
217,710
|
236,468
|
186,037
|
633,689
|
480,730
|
646,300
|
291,364
|
Capex / Sales
|
6.39%
|
6.61%
|
7.39%
|
5.21%
|
15.73%
|
11.27%
|
15.14%
|
6.71%
|
Announcement Date
|
14/05/19
|
13/05/20
|
11/05/21
|
11/05/22
|
11/05/23
|
09/05/24
|
-
|
-
|
Last Close Price
4,142
JPY Average target price
4,768
JPY Spread / Average Target +15.11% Consensus |
1st Jan change
|
Capi.
|
---|
| +41.96% | 630B | | -7.15% | 350B | | +18.77% | 328B | | +8.79% | 298B | | +18.02% | 246B | | +1.27% | 225B | | +11.95% | 218B | | +3.68% | 160B | | -4.38% | 156B |
Other Pharmaceuticals
|